Results 1 - 10 of 46
- Drug Discovery for Psychiatric Disorders, CHAPTER 3 Monoaminergic Approaches for Treatment of Schizophrenia.
, Pages 35-55
- Conference on Drug Design and Discovery Technologies, Binding Studies of Antipsychotic Drug Risperidone with β-Lactoglobulin Using Fluorimetry and Molecular Modelling.
, Pages 319-329
- Designing Multi-Target Drugs, Chapter 16 Discovery of the Anti-Psychotic Drug, Ziprasidone.
, Pages 263-269
- Drug Discovery for Psychiatric Disorders, CHAPTER 15 Emerging Research towards the Understanding and Treatment of Autism.
, Pages 384-415
- Designing Multi-Target Drugs, Chapter 2 Clinical Need and Rationale for Multi-Target Drugs in Psychiatry.
, Pages 14-31
- Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 10 Alcohols and Phenols: Absorption, Distribution, Metabolism and Excretion.
, Pages 460-485
- Drug Discovery for Schizophrenia, CHAPTER 8 GSK3 Networks in Schizophrenia.
, Pages 173-201
- Nuclear Magnetic Resonance: Volume 43, Chapter 13 NMR in living systems.
, Volume 43
, Pages 495-550
- Drug Discovery for Schizophrenia, CHAPTER 5 Modelling Schizophrenia: Strategies for Identifying Improved Platforms for Drug Discovery.
, Pages 89-114
- Biotransformations: A Survey of the Biotransformations of Drugs and Chemicals in Animals, Heterocycles.
, Volume 7
, Pages 239-380